SCHEMBL4857653

SCHEMBL4857653

CCOC(=O)C1CCc2c(cc(F)c(OC)c2Cl)C1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 6/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.36
TSHR P16473 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10774544 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL10618514 0.81 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL10620628 0.75 TSHR (0.42) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL31267359 0.74 KDM4E (0.53) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL7220081 0.73 MAPT (0.52) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL31143068 0.71 PDE4A (0.40) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL7228171 0.71 KDM4E (0.56) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL8050780 0.70 MEN1 (0.55) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL4852334 0.70 KDM4E (0.45) ALDH1A1KDM4EHPGDGAA
SCHEMBL23460007 0.69 MEN1 (0.57) ALDH1A1KDM4EKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-20060041003-A1 Estrogen receptor modulators MERCK SHARP & DOHME LLC 2006-02-23 US disclosed
EP-1551820-A2 ESTROGEN RECEPTOR MODULATORS Merck & Co., Inc. (US) 2005-07-13 EP disclosed
EP-1522342-A1 PHOTOCATALYST EXHIBITING CATALYTIC ACTIVITY EVEN IN VISIBLE LIGHT REGION SUMITOMO METAL MINING COMPANY LIMITED (JP) 2005-04-13 EP disclosed
WO-2004026887-A2 ESTROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2004-04-01 WO disclosed
US-20030144140-A1 Photocatalyst exhibiting catalytic activity even in visible light region SUMITOMO METAL MINING CO., LTD. (JP) 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041003-A1 Estrogen receptor modulators GPER1, ESR2, ESR1 ALDH1A1 1646/4885KDM4E 1225/4885KMT2A 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.